SEARCH

SEARCH BY CITATION

References

  • 1
    Bamoulid J, Courivaud C, Coaquette A, et al. Subclinical Epstein–Barr virus viremia among adult renal transplant recipients: Incidence and consequences. Am J Transplant 2013; 13: 656662.
  • 2
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Transplantation 2009; 87: 436444.